Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis CRoberta D’Ambrosio, S. Fagiuoli, L. Pasulo et al.|Journal of Hepatology|2018Cited by 133
Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized studySilvia Fargion, Gemino Fiorelli, Anna Ludovica Fracanzani et al.|The American Journal of Gastroenterology|2002Cited by 80
The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective studyFrancesco Salerno, Mauro Borzio, Claudia Pedicino et al.|Liver International|2016Cited by 76
Acute torsion of uterine leiomyoma: CT featuresC. Roy, Angelo Rossini, G. Bierry et al.|Abdominal Imaging|2004Cited by 74
Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patientsGabriele Missale, Carlo Ferrari, Elisabetta Cariani et al.|Hepatology|1997Cited by 65